Cite
MLA Citation
DaeHyun Yoo et al.. “FRI0128 A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) FOR SUBCUTANEOUS ADMINISTRATION: 1-YEAR RESULTS FROM A PART 1 OF PHASE I/III RANDOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS.” Annals of the rheumatic diseases, vol. 78, n.d., p. 733. http://access.bl.uk/ark:/81055/vdc_100144730400.0x000051